Around 10,000 men die of prostate cancer each year in the UK. Yet, compared with many other common cancers, it does not attract a great deal of interest from policymakers - even in the past year, which has seen the launch of new treatments and signs of further developments on the near horizon.
In view of the low profile for what is the most common male cancer in the UK, and the ongoing developments in the prostate cancer research, Sanofi gathered together an Expert Panel of healthcare professionals and voluntary sector professionals in the prostate cancer arena, to consider the services currently received by men with the condition.
Their discussions highlighted many key issues in the UK for patients with prostate cancer, for their families, and for healthcare professionals and the voluntary sector. The issues are set out in this document, along with the Expert Panel's recommendations, in the form of the Calls to Action for Prostate Cancer.
The Forgotten 10,000 Report is available to download:
